Home » Lupin Pushes Into Generic Opportunities in the U.S. Pharmaceutical Market
Lupin Pushes Into Generic Opportunities in the U.S. Pharmaceutical Market
The U.S. was a key contributor to the overall performance on the back of a strong flu season and the Tricor launch for pharma company Lupin, says Nomura Equity Research.
moneylife
moneylife
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May